Arkansas Childrens Research

1. Sarepta Therapeutics, Inc. $934,529 607 payments
2. Global Blood Therapeutics, Inc. $167,078 57 payments
3. AbbVie, Inc. $138,018 20 payments
4. H. Lundbeck A S $113,305 13 payments
5. Shionogi Inc $84,215 12 payments
6. Paratek Pharmaceuticals, Inc. $29,429 13 payments
7. Ultragenyx Pharmaceutical Inc. $11,610 6 payments
8. Takeda Pharmaceuticals U.S.A., Inc. $9,828 5 payments
9. Agios Pharmaceuticals, Inc. $6,099 4 payments

1. Srp-9001-303 $364,838 227 payments
2. Srp-9001-301 $159,040 125 payments
3. Srp-9001-301 $123,310 77 payments
4. A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants $84,215 12 payments
5. Srp-9001-305 $67,620 50 payments
6. Srp-9001-401 $67,499 31 payments
7. An Openlabel Extension Study to Evaluate the Longterm Safety of Inclacumab Administered to Participants With Sickle Cell Disease Who Have Participated in An Inclacumab Clinical Trial $63,741 22 payments
8. Srp-9001-303 $57,775 55 payments
9. A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises $57,668 18 payments
10. A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) $55,003 6 payments

1. Patient care $639,678 435 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.